Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Clinical Biomechanics (Bristol, Avon)
|
June 21, 2019
Relationship between structural damage with loss of strength and functional disability in psoriatic arthritis patients
Carlos Manuel Feced Olmos, Oscar Alvarez-Calderon, David Hervás Marín, et al.
Annals of Translational Medicine
|
November 26, 2015
Membranous glomerulonephritis and cellular crescents induced by levamisole-adulterated cocaine abuse: a case report
Lourdes Roca-Argente, Jose-Luis Moll-Guillen, Jordi Espí-Reig, et al.
International Journal of Dermatology
|
May 13, 2024
Certolizumab pegol effectiveness, survival and safety in patients with psoriasis: A multicenter retrospective analysis in daily clinical practice by the Spanish Psoriasis Group
Antonio Sahuquillo-Torralba, Miguel Mansilla-Polo, Conrad Pujol-Marco, et al.
Journal of the American Academy of Dermatology
|
March 16, 2019
A prospective multicenter study assessing effectiveness and safety of secukinumab in a real-life setting in 158 patients
José-María Ortiz-Salvador, Martina Saneleuterio-Temporal, Jorge Magdaleno-Tapial, et al.
The Journal of Dermatological Treatment
|
April 29, 2021
The risk of hepatic adverse events of systemic medications for psoriasis: a prospective cohort study using the BIOBADADERM registry
Mónica Munera-Campos, Jaime Vilar-Alejo, Raquel Rivera, et al.
Acta Dermato-Venereologica
|
December 3, 2020
Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort
Carlos Pelayo Hernández-Fernández, Gregorio Carretero, Raquel Rivera, et al.
International Journal of Dermatology
|
September 30, 2025
Immunohistochemical Characterization of JAK Family Expression in the Primary Inflammatory Infiltrate of Lichen Planopilaris and Folliculitis Decalvans, With an Exploratory Clinical Assessment of Oral JAK Inhibitors
Miguel Antonio Lasheras-Pérez, María Concepción Garrido-Ruiz, Alejandro Lobato-Berezo, et al.
The British Journal of Dermatology
|
October 17, 2023
Safety of biologic therapy in combination with methotrexate in moderate to severe psoriasis: a cohort study from the BIOBADADERM registry
Juan José Lluch-Galcerá, Jose Manuel Carrascosa, Alicia González-Quesada, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 19, 2025
Risk of adverse events of psoriasis treatment with biologic agents and new small molecules-BIOBADADERM Registry
María Olivares-Guerrero, Esteban Daudén, Josep Riera-Monroig, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 30, 2025
Cardiovascular safety of systemic psoriasis treatments: A prospective cohort study in the BIOBADADERM registry
Juan José Lluch-Galcerá, José Manuel Carrascosa, Alicia González-Quesada, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Clinical Biomechanics (Bristol, Avon)
|
June 21, 2019
Relationship between structural damage with loss of strength and functional disability in psoriatic arthritis patients
Carlos Manuel Feced Olmos, Oscar Alvarez-Calderon, David Hervás Marín, et al.
Annals of Translational Medicine
|
November 26, 2015
Membranous glomerulonephritis and cellular crescents induced by levamisole-adulterated cocaine abuse: a case report
Lourdes Roca-Argente, Jose-Luis Moll-Guillen, Jordi Espí-Reig, et al.
International Journal of Dermatology
|
May 13, 2024
Certolizumab pegol effectiveness, survival and safety in patients with psoriasis: A multicenter retrospective analysis in daily clinical practice by the Spanish Psoriasis Group
Antonio Sahuquillo-Torralba, Miguel Mansilla-Polo, Conrad Pujol-Marco, et al.
Journal of the American Academy of Dermatology
|
March 16, 2019
A prospective multicenter study assessing effectiveness and safety of secukinumab in a real-life setting in 158 patients
José-María Ortiz-Salvador, Martina Saneleuterio-Temporal, Jorge Magdaleno-Tapial, et al.
The Journal of Dermatological Treatment
|
April 29, 2021
The risk of hepatic adverse events of systemic medications for psoriasis: a prospective cohort study using the BIOBADADERM registry
Mónica Munera-Campos, Jaime Vilar-Alejo, Raquel Rivera, et al.
Acta Dermato-Venereologica
|
December 3, 2020
Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort
Carlos Pelayo Hernández-Fernández, Gregorio Carretero, Raquel Rivera, et al.
International Journal of Dermatology
|
September 30, 2025
Immunohistochemical Characterization of JAK Family Expression in the Primary Inflammatory Infiltrate of Lichen Planopilaris and Folliculitis Decalvans, With an Exploratory Clinical Assessment of Oral JAK Inhibitors
Miguel Antonio Lasheras-Pérez, María Concepción Garrido-Ruiz, Alejandro Lobato-Berezo, et al.
The British Journal of Dermatology
|
October 17, 2023
Safety of biologic therapy in combination with methotrexate in moderate to severe psoriasis: a cohort study from the BIOBADADERM registry
Juan José Lluch-Galcerá, Jose Manuel Carrascosa, Alicia González-Quesada, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 19, 2025
Risk of adverse events of psoriasis treatment with biologic agents and new small molecules-BIOBADADERM Registry
María Olivares-Guerrero, Esteban Daudén, Josep Riera-Monroig, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 30, 2025
Cardiovascular safety of systemic psoriasis treatments: A prospective cohort study in the BIOBADADERM registry
Juan José Lluch-Galcerá, José Manuel Carrascosa, Alicia González-Quesada, et al.
Page
of 2